key: cord-0912381-7gxoeud8 authors: Qiu, Xueting; Nergiz, Ali Ihsan; Maraolo, Alberto Enrico; Bogoch, Isaac I.; Low, Nicola; Cevik, Muge title: Defining the role of asymptomatic and pre-symptomatic SARS-CoV-2 transmission – a living systematic review date: 2021-01-21 journal: Clin Microbiol Infect DOI: 10.1016/j.cmi.2021.01.011 sha: 1803c92837a667404b8655a6647ffde6c82985a1 doc_id: 912381 cord_uid: 7gxoeud8 BACKGROUND: Reports suggest that asymptomatic individuals (those with no symptoms at all throughout infection) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are infectious, but the extent of transmission based on symptom status requires further study. PURPOSE: This living review aims to critically appraise available data about secondary attack rates from people with asymptomatic, pre-symptomatic and symptomatic SARS-CoV-2 infection. DATA SOURCES: Medline, EMBASE, China Academic Journals full-text database (CNKI), and pre-print servers were searched from 30 December 2019 to 3 July 2020 using relevant MESH terms. Study selection Studies that report on contact tracing of index cases with SARS-CoV-2 infection in either English or Chinese were included. Data extraction Two authors independently extracted data and assessed study quality and risk of bias. We calculated the secondary attack rate as the number of contacts with SARS-CoV-2, divided by the number of contacts tested. Data synthesis Of 927 studies identified, 80 were included. Summary secondary attack rate estimates were 1% (95% CI: 0%-2%) with a prediction interval of 0-10% for asymptomatic index cases in 10 studies, 7% (95% CI: 3%-11%) with a prediction interval of 1- 40% for pre-symptomatic cases in 11 studies and 6% (95% CI: 5%-8%) with a prediction interval of 5- 38% for symptomatic index cases in 40 studies. The highest secondary attack rates were found in contacts who lived in the same household as the index case. Other activities associated with transmission were group activities such as sharing meals or playing board games with the index case, regardless of the disease status of the index case. LIMITATIONS: We excluded some studies because the index case or number of contacts were unclear. CONCLUSION: Asymptomatic patients can transmit SARS-CoV-2 to others, but our findings indicate that such individuals are responsible for fewer secondary infections than people with symptoms. Systematic review registration PROSPERO CRD42020188168. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) demonstrates efficient 59 transmission in populations without effective public health interventions; basic reproduction 60 numbers (R 0 ) values range between 2-3 [1] . While asymptomatic transmission has been 61 described as the "Achilles' heel" of control efforts during this pandemic, the extent to which 62 transmission of SARS-CoV-2 by people without symptoms drives this pandemic remains 63 uncertain [2] . SARS-CoV-2 infection that is asymptomatic at the time of laboratory testing is 64 widely reported [3] ; however, studies that follow infected people over time suggest that many 65 infections are not asymptomatic throughout the entire disease course, and a large proportion of 66 these individuals ultimately develop a diverse range of symptoms [4] [5] [6] [7] . For instance, Sugano et 67 al. reported a detailed cluster outbreak in music clubs in Japan, where asymptomatic cases 68 reported also included pre-symptomatic cases [8] . A living systematic review of studies published 69 up to 10 June 2020 estimated that 20% (95% CI 17 to 25%) of people who become infected with 70 SARS-CoV-2 remain asymptomatic throughout infection [7] . 71 One of the barriers to understanding the role of asymptomatic transmission is the lack of 72 consistency in case definitions [9] . While symptom severity exists on a spectrum, individuals 73 infected with SARS-CoV-2 can be miscategorized as asymptomatic, when they have milder or 74 atypical symptoms leading to overestimation of the proportion without symptoms [3, 10] . For 75 instance, in a detailed study of SARS-CoV-2 infections in Iceland where individuals deemed at 76 high risk for COVID-19 including those with a consistent syndrome were screened in a targeted 77 manner, and other individuals were tested via a population screening mechanism, more than a 78 third in the second group reported symptoms potentially consistent with COVID-19 [3]. However, 79 it is increasingly becoming clear that some individuals experience more diverse symptoms, 80 including taste and smell disturbance or myalgia, either for the entire course of illness or 81 preceding respiratory symptoms. These symptoms can be so mild and insidious that they do not 82 limit patients' daily activities [4, 11] . The situation is further complicated by subjective patient 83 perception and differences between studies in the elicitation and reporting of symptoms. 84 J o u r n a l P r e -p r o o f We defined "asymptomatic" as an individual with laboratory-confirmed SARS-CoV-2 infection but 101 without symptoms throughout their entire course of infection, or after 14 days of follow up; 102 "paucisymptomatic" as an individual with laboratory-confirmed SARS-CoV-2 infection with mild 103 symptoms, and "pre-symptomatic" as an individual who reports no symptoms at the time of the 104 initial positive test result, but who subsequently develops symptoms attributable to COVID-19. 105 We used these definitions to categorize the index cases. Secondary attack rate was defined as 106 with at least 20% of all reports being screened in duplicate to ensure consistency. Two authors 128 then independently read the full text report of all studies not excluded by title and abstract, to 129 consider eligibility for inclusion. Any disagreements regarding study inclusion were resolved 130 through discussion with a third author (MC). Data were extracted onto a standardized form. From 131 each study, the following variables were extracted: the name of the first author, year of 132 publication, country, sample size, details of index cases (categorised as asymptomatic, pre-133 symptomatic and symptomatic); event details such as environment, transmission details; number 134 of contacts, number of secondary cases. If these data were not reported, we contacted authors 135 to request them and checked with the authors about all symptoms that they sought. The studies are summarized in text and table form, descriptive statistics were completed for key 145 outcome measures. Secondary attack rates were computed from raw data in each study, dividing 146 the number of infected contacts of primary cases by the total number of susceptible exposed 147 contacts. A pooled analysis was carried out to generate summary estimates for the secondary 148 attack rate in each subgroup analyzed (asymptomatic, pre-symptomatic and symptomatic index 149 cases), in the framework of a random effect model. The Freeman -Tukey double-arcsine 150 variance-stabilizing transformation was used to combine data, due to its advantage over log and 151 logit transformations which did not allow to compute the proportion in the presence of zero event 152 counts [15] . Secondary attack rates are presented as a proportion along with 95% CIs in forest 153 plots. Heterogeneity between study estimates was gauged by means of the Cochran's Q and I 2 154 statistic: an I 2 value above 75% indicates high heterogeneity Ten studies were included in the quantitative analysis (Table 1) [6, 13, 22-29]. Summary 173 secondary attach rate estimate was 1% (95% CI: 0%-2%) with a prediction interval ranged of 0-174 10% ( Figure 2 ). All except one tested all close contacts for SARS-CoV-2, regardless of 175 (Table 2 ). Of those, eleven studies were included in the quantitative analysis. The summary SAR 211 estimate was 7% (95% CI: 3%-11%) with a prediction interval of 1 to 40% (Figure 3 ). These 212 studies followed up 22 to 585 close contacts whose initial exposure occurred before symptom 213 onset of the index case. Even in studies that followed up large numbers of people, including 214 community contacts, the majority of secondary cases identified were from the same household or 215 among friend gatherings. In these studies, having meals together, or playing cards with the index 216 case were exposure activities associated with transmission. The remaining one study reported 217 an outbreak in a restaurant [40] and four studies exclusively reported family cluster outbreaks 218 [30, 32, 33, 39] ; these investigations did not test contacts outside the household, and it is 219 challenging to truly differentiate transmission during the pre-symptomatic period from 220 symptomatic transmission in the household setting (Supplementary Figure 1) transmission dynamics. In this systematic review, we found that index cases with symptoms had 263 a higher secondary attack rate compared with truly asymptomatic index cases. While there is a 264 need to better understand this difference, it may be due to shorter duration of infectiousness. In a 265 living systematic review including of studies published up to 6 June 2020, we found that cases 266 with asymptomatic people had a shorter duration of RNA shedding than symptomatic individuals 267 [85] . Asymptomatic patients may therefore be contagious but for a shorter duration than 268 symptomatic people; this might contribute to lower transmission to their contacts. However, we 269 do Secondly, we only included studies with clear case definitions, which indicated the number of 296 contacts and secondary cases. We excluded studies in which the index case was unclear, or the 297 numbers of contacts were not provided. The estimates from individual studies are also subject to 298 limitations, such as imprecision resulting from small study size, and multiple sources of bias in 299 the estimation of the true secondary attack rate, which are detailed in this paper [89] . Moreover, 300 while the number of index cases could influence the confidence interval estimation for secondary 301 attack rate due to heterogeneity among index cases, we have constructed a prediction interval to 302 yield conservative confidence interval estimates. 303 304 We identified two other systematic reviews that investigated asymptomatic transmission, with 305 different research questions, which results in different search terms and studies retrieved. One 306 living systematic review, which included studies published up to 10 June 2020, identified five 307 studies that directly compared secondary attack rates between asymptomatic and symptomatic 308 index cases; all were included in our review [7] . This study only included studies that provided 309 data to allow relative risks to be estimated. The summary risk ratios for asymptomatic versus 310 symptomatic (0.35, 95% CI 0.10, 1.27) and pre-symptomatic versus symptomatic (0.63, 95% CI 311 0.18, 2.26) are consistent with our findings. The second review estimated only household 312 secondary attack rates and included studies published up to 29 July 2020 [90] . Of three studies 313 that included asymptomatic index cases, two were included in our review. We excluded one of 314 the studies because the number of contacts of asymptomatic index cases was not specified; we 315 have not yet received details of the study after contacting the authors. Advantages of our review 316 over these two studies are inclusion of studies published in Chinese, search terms that aimed to 317 capture studies specifically estimating secondary attack rates. 318 319 In summary, whilst asymptomatic transmission is a major concern for SARS-CoV-2 community 320 spread, secondary attack rates from those who remain asymptomatic throughout their 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 Records identified For each study the secondary attack rate is reported with its 95% CI. 414 A prediction interval at the bottom of the forest is depicted. 415 416 417 418 Figure 3 : Secondary attack rates from pre-symptomatic index cases to their contacts 419 420 For each study the secondary attack rate is reported with its 95% CI. 422 A prediction interval at the bottom of the forest is depicted. The Lancet Infectious 471 Diseases Korea National Committee for Clinical Management of Travel Medicine and 545 Infectious Disease Chung 553 Hua Liu Hsing Ping Hsueh Tsa Chih Singapore Novel Coronavirus Outbreak Research The Lancet Infectious Diseases Epidemiological analysis of 67 local COVID-19 clusters in Sichuan Province, China, 596 Research Square Low and high infection dose 600 transmission of SARS-CoV-2 in the first COVID-19 clusters in Northern Germany, medRxiv Chung 607 Hua Yu Fang I Hsueh Tsa Chih Household transmission of COVID-19 Chung Hua Liu Hsing Ping Hsueh Tsa Chih Chung Hua Liu Hsing Ping Hsueh Tsa Chih Chung 623 Hua Liu Hsing Ping Hsueh Tsa Chih 647 Basic epidemiological parameter values from data of real-world in mega-cities: the 648 characteristics of COVID-19 in Beijing The Lancet Infectious Diseases The Lancet Microbe The Lancet Infectious Diseases The 685 Lancet Infectious Diseases